Victor Moyo

Technik-/Wissenschafts-/F&E-Leiter bei TRAWS PHARMA, INC.

Finance

Health Technology

Consumer Services

Aktive Positionen von Victor Moyo

Unternehmen	Position	Beginn	Ende
TRAWS PHARMA, INC.	Technik-/Wissenschafts-/F&E-Leiter	24.10.2023	-
OncoPep, Inc. OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.	Corporate Officer/Principal	01.05.2022	-

University of Zimbabwe

Doctorate Degree

International

Vereinigte Staaten	3
Simbabwe	2

Operativ

Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
TRAWS PHARMA, INC.	Health Technology

Private Unternehmen	1
OncoPep, Inc. OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.	Finance

Private Unternehmen

Finance